Johnson & Johnson spikes over 3% after nearly $9B settlement on talc claims

Shares of Johnson & Johnson are up approximately $5 per share or over 3% in after-hours trading on Tuesday to $164 per share after announcing a nearly $9B settlement over claims that its talcum powder causes cancer.